Business

Canadian pharmaceutical manufacturer Optimi Health has completed a commercial export of GMP-grade psilocybin capsules to Australia under the Therapeutic Goods...

The psychedelic medicine sector has entered its most important phase yet. The hype cycle is over. The speculative frenzy that...

Australian psychedelic-assisted therapy provider Emyria has reported encouraging early results from its treatment-resistant depression program, marking another important milestone for...

Compass Pathways has moved closer than any company in the psychedelic medicine sector to securing U.S. regulatory approval for a...

The psychedelic medicine sector has reached an important inflection point. After years of scientific breakthroughs, headline-grabbing clinical trial results and...

Australia's emerging psychedelic medicine sector is warning that proposed federal tax reforms could undermine the country's ability to attract investment...

Five years ago, psychedelic stocks were among the hottest stories in biotechnology. Investors poured money into companies developing treatments based...

Australian pharmaceutical and psychedelic medicines company Bioxyne has announced the appointment of experienced investor and business executive Edward Myer as...

Today, Bioxyne found itself in the national spotlight. An ABC news segment featured the company's pharmaceutical manufacturing operations, including medicinal...

From Melbourne Cannabis Startup to NASDAQ Biotech Contender When historians eventually document Australia's contribution to the modern psychedelic medicine movement,...